BRIEF published on 05/08/2024 at 10:06, 1 year 10 months ago Finnvera Oyj annonce une croissance financière positive au premier trimestre 2024 Croissance Financière Financement Durable Finnvera Oyj Performances Du Premier Trimestre 2024 Crédit À L'exportation
BRIEF published on 05/08/2024 at 10:05, 1 year 10 months ago Sto SE & Co. KGaA Reports a Decline in Q1 2024 Revenue Revenue Decline Q1 2024 Sto SE & Co. KGaA Building Coatings Investment Forecast
BRIEF published on 05/08/2024 at 10:05, 1 year 10 months ago Sto SE & Co. KGaA annonce une baisse de son chiffre d'affaires au premier trimestre 2024 Baisse Des Revenus Sto SE & Co. KGaA Revêtements De Bâtiment T1 2024 Prévisions D'investissement
BRIEF published on 05/08/2024 at 09:07, 1 year 10 months ago Borussia Dortmund Expected to Gain Financially from Recent Successes Financial Analysis Borussia Dortmund UEFA Champions League Executive Board Changes Market Recommendation
BRIEF published on 05/08/2024 at 09:07, 1 year 10 months ago Le Borussia Dortmund devrait profiter financièrement de ses récents succès Analyse Financière Borussia Dortmund UEFA Ligue Des Champions Changements Au Sein Du Conseil D'administration Recommandation Du Marché
BRIEF published on 05/08/2024 at 09:05, 1 year 10 months ago Medincell Temporarily Suspends its Euronext Paris Listing Euronext Paris Press Release Financial Markets Medincell Share Suspension
BRIEF published on 05/08/2024 at 09:05, 1 year 10 months ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Marchés Financiers Communiqué De Presse Médine Partager La Suspension
BRIEF published on 05/08/2024 at 09:04, 1 year 10 months ago RHÖN-KLINIKUM AG Reports Strong Start to 2024 with Positive First Quarter Results 2024 Outlook Healthcare Industry Economic Impact RHÖN-KLINIKUM AG Q1 Financial Results
BRIEF published on 05/08/2024 at 09:04, 1 year 10 months ago RHÖN-KLINIKUM AG annonce un bon début d'année 2024 avec des résultats positifs au premier trimestre Perspectives 2024 L'industrie De La Santé Impact Economique RHÖN-KLINIKUM AG Résultats Financiers Du Premier Trimestre
BRIEF published on 05/08/2024 at 09:01, 1 year 10 months ago Edison Research Highlights Canadian General Investments' Strong Performance Investment Opportunity Dividend Policy Canadian General Investments Long-term Performance Stock Selection Strategy
Published on 03/12/2026 at 11:00, 18 minutes ago Firefox Gold Welcomes Mr. Martin Rip To Its Board Of Directors
Published on 03/11/2026 at 23:00, 12 hours 18 minutes ago Redwood AI Enhances Its Chemical Synthesis Platform with Industry-Grade Integrated Safety Functionality, Streamlining User Chemical Development Processes
Published on 03/11/2026 at 22:55, 12 hours 23 minutes ago Pathfinder Ventures Announces Closing of Parksville Refinancing and Extension of Private Placement
Published on 03/12/2026 at 11:00, 18 minutes ago Merger with impact: MG Health and Canify form an international leading medical cannabis provider
Published on 03/12/2026 at 11:00, 18 minutes ago ABB Ltd: ABB share buybacks - March 5, 2026 - March 11, 2026
Published on 03/12/2026 at 10:30, 47 minutes ago Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 03/12/2026 at 10:20, 57 minutes ago StageOne Ventures Announces Closing of $165M Fifth Fund to Fuel Israel's Next Generation of AI Infrastructure Leaders
Published on 03/12/2026 at 10:55, 22 minutes ago Déclaration des transactions sur actions propres réalisées le 09/03/2026
Published on 03/12/2026 at 10:55, 22 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 08:30, 2 hours 48 minutes ago Claude Bernard lance Claude Bernard Compléments alimentaires en partenariat avec Synadiet
Published on 03/12/2026 at 07:30, 3 hours 48 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/12/2026 at 07:30, 3 hours 48 minutes ago Biophytis et LynxKite renforcent leur alliance pour accélérer la découverte de médicaments dédiés à la longévité grâce à l’IA
